by Shi-qi An | Dec 4, 2024 | News
Series A financing highlights the potential impact of Abselion’s technology for life science research and bioprocess development Abselion, an innovator in automated analytical instrumentation that simplifies at-line protein quantification, has secured £6.6 million in...
by Shi-qi An | Sep 17, 2024 | News
Abselion is delighted to announce the appointment of Dr Anne Jones to the board of the company as non-executive director. Anne brings over 25 years of global commercial experience in the Life Sciences, Healthcare and Cell Therapy arenas working with world class...
by Shi-qi An | Aug 20, 2024 | News
Collaborative Project to Develop Next-Generation Cell Platform for Viral Vector Manufacturing Receives £1.1 Million Grant from Innovate UK & NRC Cambridge (UK) & Montreal (Canada), August 20th 2024 In a ground-breaking collaboration, leading biotechnology...
by Shi-qi An | Dec 8, 2023 | News
Abselion is celebrating a significant achievement winning the coveted Bioprocessing Industry Association 2023 award for Next-Gen Analytics at the annual industry gathering. This recognition comes in light of Amperia, a groundbreaking benchtop tool designed to...
by Shi-qi An | Oct 20, 2021 | News
At ELRIG Drug Discovery 2021, Abselion (trading name of HexagonFab Ltd) received the Innovation AveNEW top startup company award from SLAS (Society for Laboratory Automation and Screening)! About SLAS The Society for Laboratory Automation and Screening (SLAS) is an...
by Shi-qi An | Apr 20, 2021 | News
Abselion (trading name of HexagonFab Ltd) has secured £1.9m (USD 2.6m) seed funding to launch the Bolt, an analytical lab instrument to speed discovery and production of next-generation biopharmaceuticals The system provides convenient and affordable access to...
